Answers are grounded in this paper and cite their sources.
Observational analysis reveals correlations between betaine and brain structural changes in schizophrenia, suggesting a role in disease pathology.
Previous studies on metabolic profiling have shown decreased plasma levels of betaine in schizophrenia. Betaine serves as a substrate of betaine-homocysteine methyltransferase, which converts homocysteine to methionine. A decrease in betaine may lead to the elevation of homocysteine and an insufficient supply of methyl donors, which may affect DNA methylation. To explore how decreased betaine levels could affect brain structural changes often observed in schizophrenia, the present study investigated the relationships in 27 patients with chronic schizophrenia and 49 healthy comparison individuals. We found that the effects of betaine on brain volume are group-specific, and significant correlations between betaine and notable brain areas implicated in schizophrenia's pathophysiology including the superior temporal gyrus. These findings suggest that betaine levels may contribute to aberrant structural changes in schizophrenia.
No takes yet. Share an insight, caveat, or question.
Omileke et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: